Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$284K Sell
3,582
-874
-20% -$69.5K 0.14% 101
2025
Q1
$400K Sell
4,456
-1,156
-21% -$108K 0.22% 79
2024
Q4
$558K Buy
5,612
+1,349
+32% +$139K 0.29% 53
2024
Q3
$484K Hold
4,263
0.4% 42
2024
Q2
$528K Hold
4,263
0.47% 34
2024
Q1
$563K Sell
4,263
-282
-6% -$34.8K 0.52% 34
2023
Q4
$495K Buy
+4,545
New +$472K 0.48% 35

Other funds holding MRK

Breed's Hill Capital's MRK Position: Q2 2025 in Review

Breed's Hill Capital reduced its Merck (MRK) stake by 20% in Q2 2025, selling an estimated $69.5K and leaving 3,582 shares worth $284K. The position accounts for 0.14% of the portfolio, ranked #101.

Breed's Hill Capital first reported a position in MRK in Q4 2023 and has held it in 7 quarters since. The position peaked at $563K in Q1 2024. 3,332 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Breed's Hill Capital held 3,582 shares of Merck worth $284K as of Q2 2025.
  • Breed's Hill Capital sold 874 Merck shares in Q2 2025, an estimated $69.5K.
  • Merck made up 0.14% of Breed's Hill Capital's portfolio in Q2 2025, its #101 holding.
  • Breed's Hill Capital first reported a position in Merck in Q4 2023 and has held it in 7 quarters since.
  • Breed's Hill Capital's Merck position peaked at $563K in Q1 2024.
  • 3,332 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.